Literature DB >> 29773627

Draft Whole-Genome Sequences of Chryseobacterium piscicola and Chryseobacterium shigense.

Cynthia B Stine1, Cong Li2, Tina C Crosby2, Nicholas R Hasbrouck2, Claudia Lam2, Daniel A Tadesse2.   

Abstract

We report the draft whole-genome sequences for Chryseobacterium piscicola and Chryseobacterium shigense type strains, bacteria that have been associated with fish gill disease.

Entities:  

Year:  2018        PMID: 29773627      PMCID: PMC5958254          DOI: 10.1128/genomeA.00413-18

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Gill disease is an important disease of cultured fish worldwide. We sequenced the Chryseobacterium species in this report based on their prior association with fish and gill disease (1–4). The purpose is to facilitate investigation of the etiologic agents of gill disease in the United States. Chryseobacterium spp. type strains were obtained from the Leibniz Institute DSMZ–German Collection of Microorganisms and Cell Cultures (DSM). DNA was extracted using a MO BIO Ultra Clean microbial DNA isolation kit (MO BIO Laboratories, Inc., Carlsbad, CA, USA) according to the manufacturer’s recommendations. Whole-genome sequencing (WGS) was performed using v3 chemistry with paired-end 2× 300-bp reads on the MiSeq platform (Illumina, San Diego, CA, USA). Sequencing libraries were prepared according to the Illumina Nextera XT sample preparation guide. WGS data were imported into CLC Genomics Workbench, and a de novo assembly was performed using default CLC Genomics Workbench version 8.0 assembly parameters (Qiagen, Valencia, CA, USA). Contigs of less than 300 bp were removed from analysis. The genomes were annotated using the NCBI Prokaryotic Genomes Annotation Pipeline (PGAP V4) (https://www.ncbi.nlm.nih.gov/genome/annotation_prok/). WGS assembly data are shown in Table 1.
TABLE 1

Summary of analyses of type strains associated with fish gill disease

Sample no.StrainSpeciesNo. of contigsAssembly size (bp)G+C content (%)Coverage (×)Total no. of genesTotal no. of CDSaNo. of coding CDSNo. of RNA genesGenBank accession no.
CVM 43419DSM 21068Chryseobacterium piscicola433,444,09733.821183,1103,0593,02551MUGO00000000
CVM 43418DSM 17126Chryseobacterium shigense424,895,12537.47814,4244,3534,30971MUGP00000000

CDS, coding DNA sequences.

Summary of analyses of type strains associated with fish gill disease CDS, coding DNA sequences. The publicly available resistance gene database ResFinder was used for identification of antimicrobial resistance genes, with a 90% sequence identity and 60% length minimum used to identify resistance genes (5). None of the sequenced isolates carried acquired resistance genes.

Accession number(s).

These draft genomes have been deposited in GenBank under the accession no. indicated in Table 1.
  5 in total

1.  Diversity of fish-associated flavobacteria of Michigan.

Authors:  T P Loch; M Fujimoto; S A Woodiga; E D Walker; T L Marsh; M Faisal
Journal:  J Aquat Anim Health       Date:  2013-09       Impact factor: 1.625

2.  Chryseobacterium piscicola sp. nov., isolated from diseased salmonid fish.

Authors:  Pedro Ilardi; Jorge Fernández; Ruben Avendaño-Herrera
Journal:  Int J Syst Evol Microbiol       Date:  2009-07-30       Impact factor: 2.747

3.  Phenotypic, serological and molecular evidence of Chryseobacterium piscicola in farmed Atlantic salmon, Salmo salar L., in Finland.

Authors:  P Ilardi; J Abad; P Rintamäki; J-F Bernardet; R Avendaño-Herrera
Journal:  J Fish Dis       Date:  2009-09-04       Impact factor: 2.767

4.  Identification of acquired antimicrobial resistance genes.

Authors:  Ea Zankari; Henrik Hasman; Salvatore Cosentino; Martin Vestergaard; Simon Rasmussen; Ole Lund; Frank M Aarestrup; Mette Voldby Larsen
Journal:  J Antimicrob Chemother       Date:  2012-07-10       Impact factor: 5.790

5.  First isolation and characterization of Chryseobacterium shigense from rainbow trout.

Authors:  Leydis Zamora; Ana I Vela; Ma Angel Palacios; Lucas Domínguez; José Francisco Fernández-Garayzábal
Journal:  BMC Vet Res       Date:  2012-06-07       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.